Narrative review / 2017
Controlled-release melatonin and doxepin are recommended as first-line therapies for insomnia in older adults.
This review evaluates pharmacologic therapies for insomnia. Controlled-release melatonin and doxepin are recommended as first-line agents in older adults, while z-drugs should be reserved if those are ineffective. For the general population, controlled-release melatonin and z-drugs can be considered for difficulty falling asleep, and low-dose doxepin and z-drugs for difficulty staying asleep. Benzodiazepines, sedating antihistamines, antiepileptics, and atypical antipsychotics are generally not recommended.
- Study type
- Narrative review
- Who was studied
- Patients with insomnia, including older adults and the general population
- What was measured
- Efficacy and safety of pharmacologic therapies for insomnia
THE PAPER
Insomnia: Pharmacologic Therapy.
Matheson E, Hainer BL. Am Fam Physician, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.